Diseases & Conditions market research reports by Inkwood Research

• United States Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032

  Nov 27, 2024  |  Published by: Inkwood Research  |  USD 1,100

  United States Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032 The United States Alzheimer’s disease therapeutics & diagnostics market is expected to grow at a CAGR of 5.75% over the forecast period of 2024-2032. The market was valued at $2551.32 million in 2023 and is expect ... Read More

• Global Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032

  Nov 27, 2024  |  Published by: Inkwood Research  |  USD 2,900

  Global Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032 The global Alzheimer’s disease therapeutics & diagnostics market was valued at $7366.84 million in 2023 and is expected to reach $12302.40 million by 2032, growing at a CAGR of 5.81% during the forecast period 2024-2032. ... Read More

• Europe Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032

  Nov 27, 2024  |  Published by: Inkwood Research  |  USD 1,600

  Europe Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032 The Europe Alzheimer’s disease therapeutics & diagnostics market is projected to develop with a CAGR of 6.07% over the forecast period 2024-2032. The market was valued at $2105.39 million in 2023 and is expected to reach ... Read More

• North America Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032

  Nov 27, 2024  |  Published by: Inkwood Research  |  USD 1,600

  North America Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032 The North America Alzheimer’s disease therapeutics & diagnostics market is estimated to develop with a CAGR of 5.60% over the forecast period 2024-2032. The market was valued at $2941.34 million in 2023 and is exp ... Read More

• Asia-pacific Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032

  Nov 27, 2024  |  Published by: Inkwood Research  |  USD 1,600

  Asia-pacific Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032 The Asia-Pacific Alzheimer’s disease therapeutics & diagnostics market is expected to grow with a CAGR of 6.18% over the forecast period 2024-2032. The market was valued at $1686.32 million in 2023 and is expected ... Read More

• Zilosul Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Oct 14, 2024  |  Published by: Inkwood Research  |  USD 550

  Zilosul Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 ZILOSUL, also known as pentosan polysulfate sodium (PPS), is a semi-synthetic medication derived from the wood chips of European beech trees. The extraction process yields glucurono-xylans, which are then sulfated to crea ... Read More

• X0002 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Oct 13, 2024  |  Published by: Inkwood Research  |  USD 550

  X0002 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 X0002, also known as ibuprofenamine hydrochloride spray, is an innovative transdermal non-steroidal anti-inflammatory drug (NSAID) currently under clinical development for the treatment of osteoarthritis (OA) and rheumatoid ... Read More

• Wegovy Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Oct 12, 2024  |  Published by: Inkwood Research  |  USD 550

  Wegovy Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 WEGOVY (Semaglutide) is a synthetic version of the human glucagon-like peptide-1 (GLP-1) hormone. It promotes weight loss by decreasing appetite, enhancing feelings of fullness, reducing food consumption, and lowering calo ... Read More

• Tlc599 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Oct 11, 2024  |  Published by: Inkwood Research  |  USD 550

  Tlc599 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 TLC599 is a proprietary formulation of dexamethasone sodium phosphate (DSP) utilizing the BioSeizer technology, designed to deliver up to 24 weeks of continuous pain relief. TLC599 offers the benefit of locally delivering ... Read More

• Sprifermin Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Oct 10, 2024  |  Published by: Inkwood Research  |  USD 550

  Sprifermin Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 Sprifermin (AS-902330) is a recombinant version of human fibroblast growth factor 18 (FGF18). Sprifermin acts as a strong agonist for FGFR2 and FGFR3 receptors. It is administered through injections directly into the j ... Read More

• Rtx-grt7039 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Oct 09, 2024  |  Published by: Inkwood Research  |  USD 550

  Rtx-grt7039 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 RTX-GRT7039 (resiniferatoxin) is an investigational drug designed for pain relief in patients with knee osteoarthritis (OA). This highly potent agonist of the Transient Receptor Potential Vanilloid 1 (TRPV1) receptor ... Read More

• Renu Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Oct 08, 2024  |  Published by: Inkwood Research  |  USD 550

  Renu Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 ReNu is a cryopreserved amniotic suspension allograft (ASA) containing micronized amniotic membrane and amniotic fluid cells. The amniotic membrane serves a protective function, surrounding the fetus and acting as a barrier ... Read More

• Mm-ii Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Oct 07, 2024  |  Published by: Inkwood Research  |  USD 550

  Mm-ii Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 MM-II is a new non-opioid intra-articular injection designed to alleviate knee pain in patients with osteoarthritis. This treatment utilizes the unique characteristics of proprietary multilamellar liposomes alongside an inn ... Read More

• Lorecivivint Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Oct 06, 2024  |  Published by: Inkwood Research  |  USD 550

  Lorecivivint Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 Lorecivivint (SM04690) is a small-molecule inhibitor targeting the Wnt pathway, delivered through intra-articular injection, and is being explored as a potential disease-modifying osteoarthritis drug (DMOAD). Preclin ... Read More

• Lna043 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Oct 05, 2024  |  Published by: Inkwood Research  |  USD 550

  Lna043 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 LNA043 is an innovative ANGPTL3 (angiopoietin-like 3) agonist designed to specifically target and repair damaged cartilage while influencing multiple pathways involved in cartilage regeneration. This drug is being explored ... Read More

• Jta-004 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Oct 04, 2024  |  Published by: Inkwood Research  |  USD 550

  Jta-004 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 JTA-004 is an innovative treatment in development for managing knee osteoarthritis pain through intra-articular injections. This advanced osteoarthritis (OA) medicine features a proprietary blend of hyaluronic acid and pl ... Read More

• Invossa Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Oct 03, 2024  |  Published by: Inkwood Research  |  USD 550

  Invossa Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 INVOSSA is a groundbreaking cell and gene therapy designed to treat knee osteoarthritis with a single intra-articular injection. Clinical trials conducted in the United States and globally have demonstrated that INVOSSA c ... Read More

• Elixcyte Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Oct 02, 2024  |  Published by: Inkwood Research  |  USD 550

  Elixcyte Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 ELIXCYTE is an allogeneic stem cell product derived from adipose tissue, designed to regulate the immune system, reduce inflammation, and promote chondrocyte proliferation while supporting the normal function of damaged ... Read More

• Cntx-4975 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Oct 01, 2024  |  Published by: Inkwood Research  |  USD 550

  Cntx-4975 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 CNTX-4975 is currently being evaluated as a treatment for moderate to severe knee osteoarthritis (OA) pain. It is a highly purified, synthetic form of trans-capsaicin administered via injection directly to the pain site ... Read More

• Amz001 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032

  Sep 30, 2024  |  Published by: Inkwood Research  |  USD 550

  Amz001 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 AMZ001 is a new topical gel formulation of diclofenac, developed specifically to treat knee osteoarthritis (OA) pain. With a high-strength concentration of 3.06% diclofenac sodium, AMZ001 stands out in the osteoarthritis m ... Read More

• Japan Cancer Pain Management Market Forecast 2024-2032

  Jul 19, 2024  |  Published by: Inkwood Research  |  USD 1,100

  Japan Cancer Pain Management Market Forecast 2024-2032 The Japan cancer pain management market is expected to grow with a CAGR of 5.75% during the forecast period 2024-2032. MARKET INSIGHTS According to the National Institutes of Health study, Cancer Prevalence Projections in Japan and Decomposition ... Read More

• Asia-pacific Bariatric Surgery Market Forecast 2024-2032

  Apr 02, 2024  |  Published by: Inkwood Research  |  USD 1,600

  Asia-pacific Bariatric Surgery Market Forecast 2024-2032 KEY FINDINGS The Asia-Pacific bariatric surgery market is projected to register a CAGR of 5.93% during the forecast period, 2024-2032. The rising incidence of obesity and medical tourism are propelling market growth in the region. MARKET INSIG ... Read More

• United States Bariatric Surgery Market Forecast 2024-2032

  Apr 02, 2024  |  Published by: Inkwood Research  |  USD 1,100

  United States Bariatric Surgery Market Forecast 2024-2032 KEY FINDINGS The United States bariatric surgery market growth is predicted to project a CAGR of 5.80% during the forecast period, 2024-2032. Bariatric surgeries, aimed at managing obesity and its related health issues, continue to be a signi ... Read More

• Global Bariatric Surgery Market Forecast 2024-2032

  Apr 02, 2024  |  Published by: Inkwood Research  |  USD 2,900

  Global Bariatric Surgery Market Forecast 2024-2032 KEY FINDINGS The global bariatric surgery market is evaluated to record a CAGR of 5.65% during the forecast period, 2024-2032. The market growth is attributed to the increasing availability and affordability of bariatric procedures, rising rates of ... Read More

• China Bariatric Surgery Market Forecast 2024-2032

  Apr 02, 2024  |  Published by: Inkwood Research  |  USD 1,100

  China Bariatric Surgery Market Forecast 2024-2032 KEY FINDINGS The China bariatric surgery market is set to register a CAGR of 5.36% during the forecast period, 2024-2032. Over the past decade, there has been a notable increase in the prevalence of obesity and related metabolic disorders in the Chin ... Read More

< prev 1 2 next >